MSP Recovery, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MSPR research report →
Price Chart
About the company
MSP Recovery, Inc. specializes in healthcare claims recovery and data analytics, serving clients throughout the United States and Puerto Rico. The company provides extensive services, enabling itself, associated parties, and third-party organizations to effectively pursue their rights for healthcare claim recovery.
- CEO
- John H. Ruiz
- IPO
- 2022
- Employees
- 78
- HQ
- Miami, FL, US
Get TickerSpark's AI analysis on MSPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.38K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- 6.05
- Div Yield
- 0.00%
- Gross Margin
- 31.51%
- Op Margin
- -23902.80%
- Net Margin
- -27535.52%
- ROE
- 156.01%
- ROIC
- -27.76%
Latest fiscal year · YoY change
- Revenue
- $18.25M+136.8%
- Gross Profit
- $8.64M+55.4%
- Op Income
- $-1,274,289,000
- Net Income
- $-360,499,000-539.8%
- EPS
- $-359.95-127.8%
- OCF Growth
- +59.7%
- FCF Growth
- +60.1%
- 52W High
- $3.75
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.08
- Beta
- -2.27
- RSI (14)
- 32
- Avg Volume
- 44.45K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
LifeWallet said Q1 was its strongest quarter yet for claims recovery, but reported a large operating loss driven mostly by non-cash amortization.· May 16, 2024
- Claims recovery income rose to $6 million from $3.5 million in Q1 2023.
- The company said Q1 was its most successful quarter-to-date since going public for claims recovery income, helped by two insurer settlements.
- A March settlement with 28 affiliated P&C insurers added historical data-sharing, future claims-resolution processes, and a confidential cash payment.
- Operating loss was $130 million, but 93% of that loss was tied to non-cash items, mainly $121 million of claims amortization.
- Management said liquidity should cover in-cash obligations for the next 12 months, supported by credit capacity and facility extensions.
For the quarter ended March 31, 2024, LifeWallet reported claims recovery income of $6 million, up from $3.5 million in Q1 2023. The company reported an operating loss of $130 million, with 93% of the loss driven by non-cash items, mostly $121 million of claims amortization expense. Other operating costs, excluding claims amortization, were $15 million. On an adjusted basis, the company posted an adjusted operating loss of $8.7 million and an adjusted net loss of $8.5 million. On the balance sheet, total assets were $3 billion, total liabilities were $1.8 billion, and current liabilities were $83 million. Management said it had extended the Virage, Nomura and Yorkville obligations to 2025, and that the working capital credit facility still had $14 million of additional borrowing capacity. No next-quarter or full-year revenue/EPS guidance was provided; management instead emphasized ongoing settlement negotiations and expected liquidity coverage over the next 12 months.
John H. Ruiz framed the quarter as a major step forward for the core claims recovery business, calling it the company’s most successful quarter-to-date since becoming public. He highlighted two comprehensive settlements with P&C insurers as proof that the model can produce a more diversified and predictable revenue stream over time. His tone was optimistic and process-oriented, emphasizing data sharing, collaborative resolution, and ongoing negotiations with additional insurers.
Francisco Rivas-Vasquez focused on the balance sheet, non-cash costs, and liquidity. He said total assets were $3 billion, mostly intangible assets carried at cost, and that total assets fell $124 million sequentially primarily due to $121 million of amortization. He noted liabilities of $1.8 billion, including $83 million in current liabilities and a $33 million warrant liability, while claims recovery income was $6 million versus $3.5 million a year ago. He also said the company had extended Virage, Nomura and Yorkville obligations to 2025, had $14 million of additional capacity under the working capital credit facility, and expected to have liquidity to meet in-cash obligations for the next 12 months.
There was no analyst Q&A because no questions were queued. As a result, there were no additional concerns or clarifications raised by analysts on the call. Management’s only forward-looking comments centered on continued settlement negotiations, future collections, and liquidity.
The company said it achieved its strongest quarter yet for claims recovery income and secured two insurer settlements that could improve future recoveries. The settlements also added data-sharing and claims-resolution mechanisms that management believes can create a more predictable revenue stream.
The quarter still included a $130 million operating loss, and the business remains heavily dependent on non-cash accounting adjustments such as $121 million of claims amortization. Management also acknowledged that future recoveries depend on litigation and settlement timing, which can be delayed, and the company still carries $1.8 billion of liabilities.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 98.1%
- Shares Outstanding
- 13.77M
- Float Shares
- 13.52M
of shares held by institutions
10 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 4, 25 | Palantir Technologies Inc. | other | 0 |
| Jan 17, 24 | Cano Health, Inc. | sell | 15,200 |
| Jan 18, 24 | Cano Health, Inc. | sell | 16,733 |
| Jan 19, 24 | Cano Health, Inc. | sell | 19,692 |
| Jan 11, 24 | Cano Health, Inc. | sell | 24,914 |
| Jan 12, 24 | Cano Health, Inc. | sell | 29,969 |
| Jan 16, 24 | Cano Health, Inc. | sell | 5,016 |
| Jan 8, 24 | Cano Health, Inc. | sell | 51,891 |
| Jan 9, 24 | Cano Health, Inc. | sell | 36,016 |
| Jan 10, 24 | Cano Health, Inc. | sell | 38,141 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MSPR coverage
Recent articles, reports, and earnings notes.
No research on MSPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MSPR report →Reviewing MSP Recovery (NASDAQ:MSPR) and CareCloud (NASDAQ:CCLD)
defenseworld.net · Apr 15
Head-To-Head Survey: MSP Recovery (NASDAQ:MSPR) & iRhythm Technologies (NASDAQ:IRTC)
defenseworld.net · Apr 6
Head to Head Survey: MSP Recovery (NASDAQ:MSPR) and 10x Genomics (NASDAQ:TXG)
defenseworld.net · Mar 7
Analyzing MSP Recovery (NASDAQ:MSPR) & SOPHiA GENETICS (NASDAQ:SOPH)
defenseworld.net · Jan 12
Short Interest in MSP Recovery, Inc. (NASDAQ:MSPR) Increases By 231.4%
defenseworld.net · Dec 26
MSP Recovery (NASDAQ:MSPR) versus Tivic Health Systems (NASDAQ:TIVC) Head-To-Head Comparison
defenseworld.net · Dec 14
MSP Recovery (NASDAQ:MSPR) Trading Down 5.8% – Here’s What Happened
defenseworld.net · Dec 11
MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers
accessnewswire.com · Dec 7
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.